Search - tctmd.com

Displaying 941 - 960 of 1038

Sort: Relevancy | Date

News Daily News

Adenosine May Be the Tie That Binds Ticagrelor and Dyspnea

Caitlin E. Cox

January 09, 2013

News Daily News

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

L.A. McKeown

December 19, 2012

News Daily News

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

L.A. McKeown

December 19, 2012

News Daily News

US Registry Data Support Wider Adoption of Transradial PCI in STEMI Patients

Caitlin E. Cox

December 19, 2012

Presentation

Safety and Efficacy of High- vs. Low-Dose Aspirin After Primary PCI in STEMI

Presenter: J. Yu

December 17, 2012

News Daily News

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Jason Kahn

December 17, 2012

News Daily News

Los betabloqueadores reducen la mortalidad a largo plazo en pacientes de alto riesgo de STEMI

Yael L. Maxwell

December 13, 2012

News Daily News

Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients

Yael L. Maxwell

December 13, 2012

News Daily News

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

L.A. McKeown

December 05, 2012

News Daily News

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

L.A. McKeown

November 28, 2012

News Conference News AHA 2012

Evidence Continues to Support Dabigatran Treatment in A-fib

November 06, 2012

News Conference News AHA 2012

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

November 04, 2012

News Daily News

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

Jason Kahn

October 19, 2012

News Daily News

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

October 12, 2012

Presentation

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

Presenter: Andr?s Kom?csi

October 01, 2012

News Daily News

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

September 27, 2012

News Conference News ESC 2012

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Caitlin E. Cox

September 04, 2012

News Conference News ESC 2012

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

August 26, 2012

News Daily News

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

L.A. McKeown

August 20, 2012

News Daily News

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

L.A. McKeown

August 20, 2012

Advertisement

Adenosine May Be the Tie That Binds Ticagrelor and Dyspnea

Una Dosis Alta de Aspirina tras una PCI Primaria aumenta las Hemorragias No observandose Beneficio Isquémico alguno

High-Dose Aspirin After Primary PCI Increases Bleeding with No Ischemic Benefit

US Registry Data Support Wider Adoption of Transradial PCI in STEMI Patients

Safety and Efficacy of High- vs. Low-Dose Aspirin After Primary PCI in STEMI

Genetic Alleles Affect Response to Prasugrel in ACS Patients

Los betabloqueadores reducen la mortalidad a largo plazo en pacientes de alto riesgo de STEMI

Beta-Blockers Reduce Long-term Mortality in High-Risk STEMI Patients

Prasugrel, Ticagrelor Show Delayed Action in STEMI Patients

Bivalirudin Shows Advantage Over GPIs—But Not Heparin Alone—in STEMI Patients

Evidence Continues to Support Dabigatran Treatment in A-fib

TRILOGY ACS Substudy: No Relationship Between Platelet Reactivity, Outcomes

Bivalirudin Lowers Bleeding in NSTEMI Patients Undergoing PCI

In Transradial PCI, Bivalirudin Fails to Budge Event Rates vs. Heparin

Use of New-Generation Oral Anticoagulant Agents in Patients Receiving Antiplatelet Therapy After an ACS

PLATO Substudy: Ticagrelor Associated with Less Bleeding, Infection, Death than Clopidogrel after CABG

ESC Congress 2012: Diverse Lineup of Practice-Changing Presentations

Prolonged Vorapaxar Enhances Secondary Prevention in Selected Post-MI Patients

Timing of Platelet Testing Key to Optimal Therapy After PCI for ACS

La programación de pruebas de plaqueta es fundamental para la estrategia de clopidogrel después de una ICP por ACS

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content